We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$82.3B
AUM Growth
+$3.23B
Cap. Flow
-$7.73B
Cap. Flow %
-9.4%
Top 10 Hldgs %
24.03%
Holding
2,474
New
201
Increased
562
Reduced
953
Closed
424

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$983M
2
EXC icon
Exelon
EXC
+$595M
3
AVGO icon
Broadcom
AVGO
+$486M
4
CRH icon
CRH
CRH
+$387M
5
MRVL icon
Marvell Technology
MRVL
+$274M

Sector Composition

Rank Sector Weight
1 Technology 23.45%
2 Financials 14.25%
3 Healthcare 13.09%
4 Industrials 10.08%
5 Consumer Discretionary 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCBC
1551
DELISTED
Macatawa Bank Corp
MCBC
$50K ﹤0.01%
5,166
-433
-8% -$4.43K
ESLT icon
1552
Elbit Systems
ESLT
$40B
$49K ﹤0.01%
237
-18
-7% -$3.75K
KNF icon
1553
Knife River
KNF
$3.83B
$49K ﹤0.01%
610
-2,104
-78% -$148K
PGEN icon
1554
Precigen
PGEN
$2.5B
$49K ﹤0.01%
34,478
-5,879
-15% -$8.44K
STOK icon
1555
Stoke Therapeutics
STOK
$2.08B
$49K ﹤0.01%
3,710
-2,069
-36% -$12.5K
TFX icon
1556
Teleflex
TFX
$6.12B
$49K ﹤0.01%
219
-19
-8% -$4.51K
NAPA
1557
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$49K ﹤0.01%
5,294
ABM icon
1558
ABM Industries
ABM
$2.82B
$48K ﹤0.01%
1,079
+1,030
+2,102% +$43.2K
FDMT icon
1559
4D Molecular Therapeutics
FDMT
$565M
$48K ﹤0.01%
1,533
-7,981
-84% -$204K
DMC
1560
Del Monte Corp
DMC
$1.44B
$48K ﹤0.01%
+1,871
New +$46.5K
FSTR icon
1561
Foster
FSTR
$433M
$48K ﹤0.01%
1,789
+1,581
+760% +$37.3K
SGHT icon
1562
Sight Sciences
SGHT
$407M
$48K ﹤0.01%
9,128
-654
-7% -$3.08K
TPB icon
1563
Turning Point Brands
TPB
$1.75B
$48K ﹤0.01%
+1,663
New +$42.4K
AXNX
1564
DELISTED
Axonics, Inc. Common Stock
AXNX
$48K ﹤0.01%
699
-48
-6% -$3.24K
NKTX icon
1565
Nkarta
NKTX
$169M
$47K ﹤0.01%
4,385
-2,225
-34% -$23.1K
SAM icon
1566
Boston Beer
SAM
$1.89B
$47K ﹤0.01%
155
SANA icon
1567
Sana Biotechnology
SANA
$955M
$47K ﹤0.01%
4,814
-2,663
-36% -$19.9K
AUTL
1568
Autolus Therapeutics
AUTL
$559M
$46K ﹤0.01%
7,372
-4,179
-36% -$26.1K
NPCE icon
1569
Neuropace
NPCE
$476M
$46K ﹤0.01%
3,541
-388
-10% -$5.53K
RRX icon
1570
Regal Rexnord
RRX
$12B
$46K ﹤0.01%
256
-11
-4% -$1.71K
SHC icon
1571
Sotera Health
SHC
$5.39B
$46K ﹤0.01%
3,852
-2,784
-42% -$41.4K
SOR
1572
Source Capital
SOR
$383M
$46K ﹤0.01%
1,087
FOR icon
1573
Forestar Group
FOR
$1.5B
$45K ﹤0.01%
1,128
-86
-7% -$2.92K
KEX icon
1574
Kirby Corp
KEX
$7.1B
$45K ﹤0.01%
+476
New +$40.2K
SLVM icon
1575
Sylvamo
SLVM
$1.54B
$45K ﹤0.01%
+730
New +$39K

Similar funds

Lazard Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Lazard Asset Management held 2,474 positions worth $82.3B, up 4.1% from $79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lazard Asset Management withdrew a net $7.73B in Q1 2024, closing 424 positions and reducing 953 holdings. Its most notable exit was PPL Corp, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in GMO US Quality ETF worth $10.8M.

  • Lazard Asset Management's largest Q1 2024 buy was GMO US Quality ETF: 362,290 shares worth $10.8M.
  • Lazard Asset Management added most to Apple in Q1 2024, an estimated $983M increase.
  • Lazard Asset Management's biggest Q1 2024 reduction was Alphabet (Google) Class A, cutting an estimated $795M.
  • Lazard Asset Management fully exited PPL Corp in Q1 2024, selling an estimated $355M.
  • Lazard Asset Management's ten largest holdings make up 24% of its $82.3B portfolio in Q1 2024.
  • Lazard Asset Management opened 201 new positions and closed 424 in Q1 2024.
  • Lazard Asset Management's portfolio value rose 4.1% quarter-over-quarter to $82.3B.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.